Gilead Sciences, Inc. (GILD)
151.00
-0.22
(-0.15%)
USD |
NASDAQ |
Sep 04, 16:00
150.90
-0.10
(-0.06%)
After-Hours: 20:00
Gilead Sciences SG&A Expense (TTM) : 9.147B for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.147B |
| March 31, 2026 | 8.591B |
| December 31, 2025 | 8.398B |
| September 30, 2025 | 5.886B |
| June 30, 2025 | 5.962B |
| March 31, 2025 | 5.974B |
| December 31, 2024 | 6.091B |
| September 30, 2024 | 5.793B |
| June 30, 2024 | 5.675B |
| March 31, 2024 | 6.147B |
| December 31, 2023 | 6.091B |
| September 30, 2023 | 6.503B |
| June 30, 2023 | 6.401B |
| March 31, 2023 | 5.909B |
| December 31, 2022 | 5.673B |
| September 30, 2022 | 5.303B |
| June 30, 2022 | 5.28B |
| March 31, 2022 | 5.274B |
| December 31, 2021 | 5.246B |
| September 30, 2021 | 5.326B |
| June 30, 2021 | 5.242B |
| March 31, 2021 | 5.13B |
| December 31, 2020 | 5.151B |
| September 30, 2020 | 4.625B |
| June 30, 2020 | 4.571B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.427B |
| December 31, 2019 | 4.381B |
| September 30, 2019 | 4.308B |
| June 30, 2019 | 4.204B |
| March 31, 2019 | 4.089B |
| December 31, 2018 | 4.056B |
| September 30, 2018 | 4.177B |
| June 30, 2018 | 4.108B |
| March 31, 2018 | 4.025B |
| December 31, 2017 | 3.878B |
| September 30, 2017 | 3.618B |
| June 30, 2017 | 3.57B |
| March 31, 2017 | 3.563B |
| December 31, 2016 | 3.398B |
| September 30, 2016 | 3.472B |
| June 30, 2016 | 3.544B |
| March 31, 2016 | 3.466B |
| December 31, 2015 | 3.426B |
| September 30, 2015 | 3.236B |
| June 30, 2015 | 3.278B |
| March 31, 2015 | 3.079B |
| December 31, 2014 | 2.983B |
| September 30, 2014 | 2.620B |
| June 30, 2014 | 2.082B |
| March 31, 2014 | 1.873B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 2.008B |
| AbbVie, Inc. | 14.67B |
| Regeneron Pharmaceuticals, Inc. | 2.743B |
| Amgen, Inc. | 7.019B |
| Biogen, Inc. | 2.594B |